Medtronic plc

MDT · CIK 0001613103

14 fiscal years · 46 SEC filings · every number carries its receipt

Revenue (FY)

$36.36B8.4%

FY2026

Net income (FY)

$4.80B3.0%

FY2026

Free cash flow (FY)

$5.43B4.6%

FY2026

Diluted EPS (FY)

$3.733.3%

FY2026

The story, charted

The shape of the business

FY2013–FY2026 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.2× since FY2013 · net margin 20.9% → 13.2%

MarginsNet marginFCF margin

FY2026: net 13.2% · free cash flow 14.9% of revenue

Cash engineOperating cash flowFree cash flow

FY2026: $7.33B operating cash − $1.90B capex = $5.43B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 16% (FY2014) → 10% (FY2026) · on assets 5.2%

Balance sheetLiabilitiesEquity

FY2026: $93.03B assets · $42.96B liabilities · $49.46B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Revenue	9,017	8,961	8,578	8,292	8,403	7,915	8,089	7,984	7,702	7,727	7,585	7,371
Net income	1,143	1,374	1,040	1,294	1,270	1,042	1,322	909	791	1,222	427	929
Diluted EPS	0.89	1.07	0.81	1.01	0.99	0.80	0.99	0.68	0.59	0.92	0.32	0.70
Diluted shares	1,290	1,288	1,287	1,286	1,287	1,297	1,332	1,332	1,334	1,332	1,332	1,335
Operating cash flow	—	—	1,088	—	—	986	—	—	875	—	—	1,083
Capital expenditures	—	—	504	—	—	520	—	—	354	—	—	426
Free cash flow	—	—	584	—	—	466	—	—	521	—	—	657
Cash & equivalents	1,147	1,282	1,273	1,240	1,394	1,311	1,623	1,311	1,339	4,521	4,828	2,140
Total assets	91,485	91,346	90,972	89,973	90,042	89,749	90,836	90,087	90,776	94,134	93,241	89,914
Total liabilities	42,289	42,489	42,839	40,358	41,326	41,589	38,840	38,440	39,410	42,516	41,184	37,071
Shareholders' equity	48,985	48,652	47,893	49,387	48,494	47,947	51,792	51,460	51,178	51,441	51,880	52,672

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.